410 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
include: the Company’s ability to secure significant additional capital as and when needed; the Company’s ability to achieve the intended benefits
8-K
EX-10.2
i51lth3x
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-2.1
k51j7rp humco4um
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-4.1
e2lb2
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
r95r2cs 807n
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
c6tt0m7jp7 7t2n
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
x9aue9z md5
25 Jan 24
Entry into a Material Definitive Agreement
8:34am
8-K
EX-10.1
bysykn 0o81pcgem
25 Jan 24
Entry into a Material Definitive Agreement
8:34am
8-K
EX-1.1
7iuflw0e ep7653p4
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
tyz2w
9 Nov 23
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
surcawjqe057xhg090vv
7 Aug 23
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
4:02pm